Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

NCT01772836 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Bacterial Infections

Interventions

DRUG: RPX7009
DRUG: Biapenem
DRUG: Normal saline

Sponsor

Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)